Skip to main content
. 2019 Sep 21;11(10):2269. doi: 10.3390/nu11102269
2-AG 2-arachidonoylglycerol
AEA anandamide
AUC area under the curve
BHB β-hydroxybutyrate
BMI body mass index
BMR basal metabolic rate
CB1 cannabinoid receptor 1
CB2 cannabinoid receptor 2
dAUC decremental area under the curve
EDTA ethylenediaminetetraacetic acid
EI energy intake
FFM fat-free mass
FM fat mass
GC-MS gas chromatography-mass spectrometry
GC-MS/MS gas chromatography-tandem mass spectrometry
GI glycemic index
GLP-1 glucagon-like peptide-1
HOMA-IR homeostatic model assessment for insulin resistance
HP/MCHO high protein/ moderate carbohydrate
iAUC incremental area under the curve
MJ megajoule
mmVAS milimeter visiual analogue scale
MP/ HCHO moderate-protein/ high-carbohydrate
OEA oleoylethanolamide
OGTT oral glucose tolerance test
PEA palmitoylethanolamide
PMSF phenylmethylsulfonyl fluoride
PREG pregnenolone
PYY polypeptide YY
TAG triacylglycerol
T2D type II diabetes
VAS visual analogue scale